We are trying to promote exclusive contracts for Anyfusion pump and ACPI system with mid-sized companies that have established European networks across the United States and centered on Germany.

After sharing published SCI-level papers with several domestic university hospitals Real world refurbce and the American Journal of Anesthesiology and Pain Medicine, and the German clinical computer and monitoring journal, we decided to visit and negotiate exclusive contracts with Anyfusion pump and ACPI system with two mid-sized companies that have established a network across the United States and Germany in November and December.

Before negotiating, we asked for a preliminary market research on two advanced market interests with different medical environments and cultures, and both companies answered that they would do their best to prepare.

All patients and guardians (general people) knew that doctors prescribe medicines based on medical and clinical grounds such as the patient's disease level and weight, and are injected and treated normally.

The infusion pump and syringe pump, which are electric drug injection pumps, accurately inject quantities (real-time injection volume is displayed on the device monitor) to restore the patient's health through normal injection treatment. Since the history of drug injection pumps, it has been confirmed in this real world reference that existing products have not been quantified, accurate, and precise injection due to original technology problems, and it has been confirmed that nurses have been working hard to control the average injection. There were extreme medical accidents such as death due to limitations in original technology, and they were used with stress about medical accident risks and inaccuracies, but they were unable to check in real time due to heavy work and emergencies.

Because there was no development until Anyfusion technology was released, FDA was aware of this problem caused by the limitations of the original technology of the existing drug injection pump, and the most problematic medical device was specially managed by a separate management department and encouraged existing companies to develop alternative technologies.

Not only the U.S. and Germany, but also around the world, are actively checking SCI papers and references and then, they have lots of interests on our products.

To treat as prescribed by medical staff, reduce heavy work, and live a healthy life with normal treatment effects, we will do our best to make a good gift to all patients around the world, not only to the two companies but also to the global market.

Thank you.